CoinShares替代币主动型ETF DIME 深 沪
等待开盘 07-01 09:30:00 美东时间
7.48
-0.020
-0.26%
华盛通- 最 高7.58
- 今 开7.58
- 成交量 437股
- 最 低 7.48
- 昨 收 7.4997
- 总市值 108.46万
- 52周最高 28.10
- 市盈率 静 --
- 换手率 0.30%
- 52周最低 7.23
- 委 比 0.00%
- 总股本 14.50万
- 历史最高 28.10
- 量 比 0.35
- 振 幅 1.33%
- 历史最低 7.23
- 每 手 1
- 风险率 4.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Motorola Solutions extends Denmark SINE TETRA network contract through 2034
Motorola Solutions extends Denmark SINE TETRA network contract through 2034 Motorola Solutions won an extension of Denmark’s national TETRA network SINE through 2034, with an option to extend to 2039. Deal upgrades SINE with DIMETRA X Core software, including DIMETRA Connect for seamless roaming bet
06-26 15:05
Motorola Solutions showcases mission-critical connectivity at Critical Communications World 2026
Motorola Solutions showcases mission-critical connectivity at Critical Communications World 2026 Motorola Solutions to showcase mission-critical connectivity and AI at Critical Communications World 2026 in London on June 16-18. Event focus includes DIMETRA Connect to link TETRA and broadband network
06-15 15:11
BRIEF-General Motors Recalling 40,440 U.S. Vehicles Over Brake Issue- NHTSA
BRIEF-General Motors Recalling 40,440 U.S. Vehicles Over Brake Issue- NHTSA May 7 (Reuters) - GENERAL MOTORS, LLC IS RECALLING 40,440 U.S. VEHICLES - NHTSA GENERAL MOTORS, LLC IS RECALLING SOME U.S. VEHICLES AS SEDIMENT IN BRAKE FLUID MAY REDUCE BRAKE PERFORMANCE, INCREASING THE RISK OF A CRASH.- NH
05-07 15:08
Arrowhead upgraded at Morgan Stanley on upcoming catalysts
Morgan Stanley upgraded Arrowhead Pharmaceuticals (ARWR) to Overweight from Equal Weight and raised its price target to $100 from $78, citing major catalysts expected from the California-based biotech...
04-22 00:51
BRIEF-Nano Dimension Ltd - No Errors Identified In Previously Issued Financial Statements No Restatement Anticipated
BRIEF-Nano Dimension Ltd - No Errors Identified In Previously Issued Financial Statements No Restatement Anticipated March 16 (Reuters) - Nano Dimension Ltd 2N5By.F : NANO DIMENSION LTD - NO ERRORS IDENTIFIED IN PREVIOUSLY ISSUED FINANCIAL STATEMENTS; NO RESTATEMENT ANTICIPATED NANO DIMENSION LTD: 2
03-16 20:14
BRIEF-Dime Announces Elevation Of Jeffrey Barber To Head Of Middle Market C&I Lending, Long Island
BRIEF-Dime Announces Elevation Of Jeffrey Barber To Head Of Middle Market C&I Lending, Long Island March 2 (Reuters) - Dime Community Bancshares Inc DCOM.O : DIME ANNOUNCES ELEVATION OF JEFFREY BARBER TO HEAD OF MIDDLE MARKET C&I LENDING, LONG ISLAND Source text: ID:nGNX9NhKql Further company covera
03-02 21:09
BRIEF-Nano Dimension Adopts Limited Duration Shareholder Rights Agreement
BRIEF-Nano Dimension Adopts Limited Duration Shareholder Rights Agreement Feb 2 (Reuters) - Nano Dimension Ltd 2N5By.F : NANO DIMENSION ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS AGREEMENT Source text: ID:nGNX1dxsdz Further company coverage: [2N5By.F] (( Reuters.Briefs@thomsonreuters.com ;))
02-03 07:30
BRIEF-Evertec To Acquire Dimensa For R$950 Million
BRIEF-Evertec To Acquire Dimensa For R$950 Million Feb 2 (Reuters) - Evertec Inc EVTC.N : EVERTEC TO ACQUIRE DIMENSA FOR R$950 MILLION Source text: ID:nBwknrLGa Further company coverage: EVTC.N (( Reuters.Briefs@thomsonreuters.com ;))
02-03 05:35
Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of Dual-Target RNAi Therapy for Mixed Hyperlipidemia
Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of Dual-Target RNAi Therapy for Mixed Hyperlipidemia Arrowhead Pharmaceuticals Inc. has announced the initiation of a Phase 1/2a clinical trial for ARO-DIMER-PA, an investigational RNA interference (RNAi) therapeutic being developed for the treatme
01-28 01:02
BUZZ-Arrowhead rises as it begins trial of high-cholesterol disorder drug
BUZZ-Arrowhead rises as it begins trial of high-cholesterol disorder drug ** Shares of Arrowhead Pharmaceuticals rise 2% to $67.95 ** California-based drugmaker says it has begun testing its experimental drug ARO-DIMER-PA for mixed hyperlipidemia, a disorder marked by high levels of cholesterol and
01-27 23:12
